Project Grant R21ES036346

Award Date 4/1/25
Completion Date 3/31/27
Dollars Obligated $457K
Federal Grant Program
93.113
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program will fund the development of high-throughput functional assays and analytical approaches to comprehensively measure DNA repair capacity across major repair pathways at single-cell resolution. The $390,366 award to The Broad Institute, Inc. will be used to generate a library of reporter plasmids to signal DNA repair in 500 well-characterized...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $244,750 to Washington State University (WSU) to conduct research on the role of the ELF1 protein in transcription-coupled nucleotide excision repair (TC-NER). The project aims to understand how ELF1 recruits the TFIIH complex to facilitate TC-NER, and how this process is regulated by phosphorylation and interactions with other...
This Project Grant award from the National Institute of Environmental Health Sciences (CFDA 93.113 - Environmental Health) will provide $364,324 to the University of North Carolina at Chapel Hill (UNC-CH) from September 2024 to April 2027 to conduct research on the evolution and genetics of thermal physiology and behavior in Drosophila flies. The key products and services to be delivered under this award include: Measuring the thermal niches and dissecting the genetic basis of thermal...
The U.S. National Institute of General Medical Sciences (NIGMS) awarded a $147,900 Project Grant (CFDA 93.859 Biomedical Research and Research Training) to Sonoma State University to conduct research on how human somatic cells regulate chromosome organization during development. The long-term goal of the 4-year study (6/15/2024 - 5/31/2028) is to uncover the mechanisms that prevent mitotic pairing and recombination of homologous chromosomes in somatic cells, which is critical for maintaining...
This $384,365 five-year Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the role of chromatin mechanics in nuclear shape and integrity. The key objectives are to: Determine the specific chromatin components and histone modifications that contribute to heterochromatin rigidity and impact nuclear mechanics, shape, and rupture. Examine whether...
This federal Project Grant award, with ID R21ES036190, was provided by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program. The goal of this $431,750 research project, running from January 2025 to January 2027, is to identify a new innate immune signaling mechanism that is triggered specifically after DNA damage has blocked transcription. The research aims to explain the mechanism by which environmental agents suppressing...
This $402,500 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the biology of supernumerary chromosomes using the B chromosome model system in Drosophila melanogaster. The 5-year project, running from July 1, 2024 to June 30, 2029, will leverage molecular, cellular, and genetic tools to study the genetic origin, stability, and transmission dynamics of...
The National Institute of General Medical Sciences (NIGMS) awarded a 5-year, $818,750 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Johns Hopkins University to investigate the mechanisms that control DNA repair pathway choice. The grant will fund two complementary research projects: Investigating how the histone variant MacroH2A1 links chromatin plasticity to DNA repair pathway choice, using isoform-specific knockout mouse models and screens to uncover how...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) program, aims to establish the fruit fly Drosophila melanogaster as a model for assessing the neurodevelopmental impacts of air pollutants, specifically diesel exhaust. The $843,410 award will be used to: 1) determine the effects of varying doses of whole and filtered diesel exhaust on neurodevelopmentally-programmed behaviors and metabolic markers in...
This $1,846,071 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports research to investigate the impact of environmental toxicants on the epigenetic regulation of the human endogenous retrovirus HML-2 in primordial germ cells. The research aims to determine how exposure to chemicals like PFOA, dieldrin, and benzo[a]pyrene can impair the epigenetic silencing of HML-2, potentially leading to...

The National Institute of Environmental Health Sciences (NIEHS) awarded a $456,500 Project Grant (CFDA 93.113 Environmental Health) to the University of Southern California (USC) to identify and characterize the Drosophila NSE5/6 protein and its functions in heterochromatin repair. The overarching goal is to illuminate the mechanisms of heterochromatin repair, which is critical for protecting the genome from environmental threats like ionizing radiation and ensuring genome stability.

Key activities include structural determination of Drosophila NSE5/6 at the atomic level, targeted mutagenesis, and in vitro and in vivo assays to define the regulatory functions and targeting mechanisms of NSE5/6 in heterochromatin repair. Expected outcomes include the first identification and characterization of Drosophila NSE5/6, as well as new insights into how this protein regulates the SMC5/6 complex to promote faithful homologous recombination repair within heterochromatin domains. This research is expected to advance the understanding of human diseases resulting from NSE5/6 dysregulation, including cancer, neurodevelopmental disorders, and viral infections.

Generated 4/8/25, 4:24 AM